Holobiome is a healthcare startup founded in 2015 and headquartered in the United States. The company's slogan "Solving the human microbiome to enable the future of health -- the answer was inside us all along." encompasses its ambition to address the complexities of the human gut microbiome. Holobiome's goal is to leverage its platform to improve human health in multiple marketplaces. The startup's initial focus is on mapping and manipulating the gut-brain-axis through next-generation probiotics. In its most recent funding round on 19 March 2024, Holobiome secured a $6.59M investment in a Venture Round. The investors behind this capital infusion have not been disclosed. With its innovative approach to the human microbiome, Holobiome shows promise in revolutionizing healthcare and pharmaceutical industries.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Venture Round | $6.59M | - | 19 Mar 2024 | |
Grant | $1.00M | 1 | 28 Oct 2021 | |
Debt Financing | $300.00K | - | 11 Feb 2021 | |
Seed Round | Unknown | 1 | 10 Apr 2019 | |
Grant | Unknown | 1 | 15 May 2017 |
No recent news or press coverage available for Holobiome.